Financial Results & Limited Review Report for Sept 30, 2015 (Standalone)
Jagsonpal Pharmaceuticals Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30, 2015.10-11-2015
10-11-2015
Shareholding Pattern for September 30, 2015
Jagsonpal Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on September 30, 2015.15-10-2015
Disclosure of Voting results of AGM (Clause 35A)
Jagsonpal Pharmaceuticals Ltd has informed BSE regarding the details of Voting results at the 36th Annual General Meeting (AGM) of the Company held on September 30, 2015, under Clause 35A of Listing Agreement.01-10-2015
Outcome of AGM
Jagsonpal Pharmaceuticals Ltd has informed BSE that the 36th Annual General Meeting (AGM) of the Company was held on September 30, 2015.30-09-2015
AGM on Sept 30, 2015
Jagsonpal Pharmaceuticals Ltd has informed BSE that the 36th Annual General Meeting (AGM) of the Company will be held on September 30, 2015.10-09-2015
Fixes Book Closure for Dividend & AGM
Jagsonpal Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2015 to September 30, 2015 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company to be held on September 30, 2015.17-08-2015
Financial Results & Limited Review Report for June 30, 2015 (Standalone)
Jagsonpal Pharmaceuticals Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended June 30, 2015.13-08-2015
Shareholding Pattern For June 30, 2015
Jagsonpal Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on June 30, 2015.15-07-2015
Clause 20
Jagsonpal Pharmaceuticals Ltd has submitted to BSE a copy of Clause 20 as per the Listing Agreement for period ended March 31, 2015.16-06-2015
Code of Conduct of Fair Disclosure
Jagsonpal Pharmaceuticals Ltd has informed BSE that Pursuant to Regulation 8 & 9 of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015, the Company has submitted the Code of Practices and procedures for fair disclosure of Unpublished Price Sensitive Information.08-06-2015